Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OptiNose, Inc. | Director | Stock Option (Right to Buy) | 32K | Jun 8, 2022 | Direct | ||
Acurx Pharmaceuticals, Inc. | Director | Stock Option | 12K | Jun 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACXP | Acurx Pharmaceuticals, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
ACXP | Acurx Pharmaceuticals, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
OPTN | OptiNose, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
ACXP | Acurx Pharmaceuticals, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director |
ACXP | Acurx Pharmaceuticals, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director |
OPTN | OptiNose, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
OPTN | OptiNose, Inc. | May 10, 2021 | 1 | $29.9K | 4 | May 11, 2021 | Director |